TAK-715   Click here for help

GtoPdb Ligand ID: 9328

Synonyms: compound 8h [PMID: 16162000] | TAK 715 | TAK0715
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: TAK-715 was developed as a p38 MAP kinase inhibitor, with anti-TNFα activity of potential clinical use as an anti-rheumatoid arthritis (RA) agent [1]. TAK-715 is now available for repurposing via the MRC-Industry Asset Sharing Initiative 2016 (full compound list).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 83.12
Molecular weight 399.14
XLogP 5.42
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES CCc1nc(c(s1)c1ccnc(c1)NC(=O)c1ccccc1)c1cccc(c1)C
Isomeric SMILES CCc1nc(c(s1)c1ccnc(c1)NC(=O)c1ccccc1)c1cccc(c1)C
InChI InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28)
Bioactivity Comments
TAK-715 inhibits LPS-induced TNFα production in vitro and in vivo, shows good bioavailability in rodents and no inhibitory activity for major CYP450 drug-metabolising enzymes [1]. It shows efficacy in a rat adjuvant-induced arthritis model.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
mitogen-activated protein kinase 14 Primary target of this compound Hs Inhibitor Inhibition 8.1 pIC50 - 1
pIC50 8.1 (IC50 7.1x10-9 M) [1]
mitogen-activated protein kinase 11 Hs Inhibitor Inhibition 6.7 pIC50 - 1
pIC50 6.7 (IC50 2x10-7 M) [1]